Article By:
The Life Sciences Report
Monday, September 7, 2015 8:00 AM EDT
Ran Nussbaum, managing partner with The Pontifax Group, doesn't worry too much about overall market volatility. Biotechs, he feels, are somewhat immune to turmoil because their fundamentals are based in real life.
In this article: AZN, BMY, JNJ, LLY, MRK, NVS, OPK, PFE, ALPMF, BAYRY, RHHBY, ARRY, BMRN, IMGN, MDVN, SGEN, CELG, CLVS, EXEL, GILD, TEVA, SAGE, MRNS, KITE, BLUE, FMI, ARNI
